Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous fumarate + folic acid + cyanocobalamin is a fixed-dose combination of three active ingredients: - Ferrous fumarate (an iron salt) replenishes iron stores and supports the production of hemoglobin and red blood cells. - Folic acid (vitamin B9) is essential for nucleotide biosynthesis, remethylation of homocysteine, and the formation of red blood cells. It also plays a critical role in fetal neural tube development. - Cyanocobalamin (vitamin B12) is vital for DNA synthesis, cell division, neurological function, and erythropoiesis. This combination is primarily used to treat or prevent nutritional deficiencies such as iron deficiency anemia, megaloblastic anemia due to vitamin B12 or folic acid deficiency, and to support increased nutritional needs during pregnancy or recovery from illness. The mechanism involves direct supplementation—iron supports hemoglobin synthesis; folic acid enables proper cell division; cyanocobalamin ensures normal nerve function and hematopoiesis[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous fumarate + folic acid + cyanocobalamin.